LexDanaLexDanabeta
Inventor

Mark Frewin

Inventor
Oxford, GB

Overview

8→
Patents
2008–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 8 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes38%
C07KPeptides38%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
PatentTitleYear
10,800,850Therapeutic antibodies20208,623,357'Therapeutic antibodies'20148,440,190'Antibody variants'20137,994,289'Humanized anti-CD3 antibodies'20117,993,641'Methods of treatment using anti-CD3 antibodies'20117,947,272'Compositions and methods of tolerizing a primate to an antigen'20117,541,443'Anti-CD4 antibodies'20097,465,790'Therapeutic antibodies'2008

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2008–2020Based in Oxford, GB· patent location history
2009–2014Patents assigned to ISIS INNOVATION (4)· patent assignee history
2009–2011Patents assigned to UNIV CAMBRIDGE TECH (2)· patent assignee history
2011Patents assigned to BTG INT LTD (2)· patent assignee history
2013Patents assigned to FREWIN MARK R (1)· patent assignee history
2020Patents assigned to CYTOMX THERAPEUTICS INC (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ISIS INNOVATION42009–2014
BTG INT LTD22011
UNIV CAMBRIDGE TECH22009–2011
CYTOMX THERAPEUTICS INC12020
FREWIN MARK Rself12013
Locations
LocationPatentsSpan
Oxford, GB82008–2020